CN114053175B - 一种祛痘产品及其制备方法 - Google Patents
一种祛痘产品及其制备方法 Download PDFInfo
- Publication number
- CN114053175B CN114053175B CN202111343645.1A CN202111343645A CN114053175B CN 114053175 B CN114053175 B CN 114053175B CN 202111343645 A CN202111343645 A CN 202111343645A CN 114053175 B CN114053175 B CN 114053175B
- Authority
- CN
- China
- Prior art keywords
- acne
- phase
- essential oil
- extract
- removing product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 208000002874 Acne Vulgaris Diseases 0.000 title claims abstract description 92
- 206010000496 acne Diseases 0.000 title claims abstract description 92
- 238000002360 preparation method Methods 0.000 title abstract description 30
- 238000004519 manufacturing process Methods 0.000 title abstract description 6
- 239000000341 volatile oil Substances 0.000 claims abstract description 70
- 239000000284 extract Substances 0.000 claims abstract description 62
- 239000002994 raw material Substances 0.000 claims abstract description 41
- 241000196324 Embryophyta Species 0.000 claims abstract description 34
- 239000003961 penetration enhancing agent Substances 0.000 claims abstract description 34
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 31
- 239000000203 mixture Substances 0.000 claims abstract description 30
- 240000000599 Lentinula edodes Species 0.000 claims abstract description 29
- 235000001715 Lentinula edodes Nutrition 0.000 claims abstract description 25
- 239000002904 solvent Substances 0.000 claims abstract description 25
- 239000003906 humectant Substances 0.000 claims abstract description 21
- 244000183685 Citrus aurantium Species 0.000 claims abstract description 19
- 235000007716 Citrus aurantium Nutrition 0.000 claims abstract description 19
- 244000166675 Cymbopogon nardus Species 0.000 claims abstract description 16
- 235000018791 Cymbopogon nardus Nutrition 0.000 claims abstract description 16
- 239000002562 thickening agent Substances 0.000 claims abstract description 14
- -1 antiseptic Substances 0.000 claims abstract description 13
- 239000002131 composite material Substances 0.000 claims abstract description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 30
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 29
- 239000003755 preservative agent Substances 0.000 claims description 24
- 230000002335 preservative effect Effects 0.000 claims description 23
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 20
- 244000147568 Laurus nobilis Species 0.000 claims description 15
- 235000017858 Laurus nobilis Nutrition 0.000 claims description 15
- 235000005212 Terminalia tomentosa Nutrition 0.000 claims description 15
- NYGZYUAVZPIKBZ-BDJLRTHQSA-N Kushenin Natural products O(C)c1c(O)cc2O[C@H]3[C@@H](c2c1)COc1c3ccc(O)c1 NYGZYUAVZPIKBZ-BDJLRTHQSA-N 0.000 claims description 14
- NYGZYUAVZPIKBZ-UHFFFAOYSA-N Lespedezol D1 Natural products C1OC2=CC(O)=CC=C2C2C1C(C=C(C(=C1)O)OC)=C1O2 NYGZYUAVZPIKBZ-UHFFFAOYSA-N 0.000 claims description 14
- NYGZYUAVZPIKBZ-ZBEGNZNMSA-N lespedezol D1 Chemical compound C1OC2=CC(O)=CC=C2[C@H]2[C@@H]1C(C=C(C(=C1)O)OC)=C1O2 NYGZYUAVZPIKBZ-ZBEGNZNMSA-N 0.000 claims description 14
- 239000004359 castor oil Substances 0.000 claims description 13
- 235000019438 castor oil Nutrition 0.000 claims description 13
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 13
- APZYKUZPJCQGPP-UHFFFAOYSA-N Tetrahydropiperine Chemical compound C=1C=C2OCOC2=CC=1CCCCC(=O)N1CCCCC1 APZYKUZPJCQGPP-UHFFFAOYSA-N 0.000 claims description 12
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 11
- 229920000858 Cyclodextrin Polymers 0.000 claims description 11
- WYQVAPGDARQUBT-FGWHUCSPSA-N Madecassol Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O)OC[C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)[C@]12CC[C@H]([C@@H]([C@H]1C=1[C@@]([C@@]3(CC[C@H]4[C@](C)(CO)[C@@H](O)[C@H](O)C[C@]4(C)[C@H]3CC=1)C)(C)CC2)C)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O WYQVAPGDARQUBT-FGWHUCSPSA-N 0.000 claims description 11
- 108010039918 Polylysine Proteins 0.000 claims description 11
- WYQVAPGDARQUBT-XCWYDTOWSA-N asiaticoside Natural products O=C(O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@H](O)[C@H](O)[C@H](O[C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)[C@@H](CO)O2)O1)[C@@]12[C@@H]([C@@H](C)[C@H](C)CC1)C=1[C@](C)([C@@]3(C)[C@@H]([C@@]4(C)[C@H]([C@@](CO)(C)[C@@H](O)[C@H](O)C4)CC3)CC=1)CC2 WYQVAPGDARQUBT-XCWYDTOWSA-N 0.000 claims description 11
- 229940022757 asiaticoside Drugs 0.000 claims description 11
- QCYLIQBVLZBPNK-UHFFFAOYSA-N asiaticoside A Natural products O1C(C(=O)C(C)C)=CC(C)C(C2(C(OC(C)=O)CC34C5)C)C1CC2(C)C3CCC(C1(C)C)C45CCC1OC1OCC(O)C(O)C1O QCYLIQBVLZBPNK-UHFFFAOYSA-N 0.000 claims description 11
- 229960005323 phenoxyethanol Drugs 0.000 claims description 11
- 229920000656 polylysine Polymers 0.000 claims description 11
- 239000004721 Polyphenylene oxide Substances 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 10
- 229920000570 polyether Polymers 0.000 claims description 10
- 229920002101 Chitin Polymers 0.000 claims description 9
- POQHFALZNYMCBA-UHFFFAOYSA-N Stemonine Natural products CCC1C2C3CCC(C4CC(C)C(=O)O4)N3CCC(=O)C2OC15OC(=O)C(=C5)C POQHFALZNYMCBA-UHFFFAOYSA-N 0.000 claims description 9
- GYOGHROCTSEKDY-UHFFFAOYSA-N Tuberostemonine J Natural products C12N3CCCCC1C(CC)C1OC(=O)C(C)C1C2CC3C1CC(C)C(=O)O1 GYOGHROCTSEKDY-UHFFFAOYSA-N 0.000 claims description 9
- 229940067866 dandelion extract Drugs 0.000 claims description 9
- 235000020691 dandelion extract Nutrition 0.000 claims description 9
- UINUUSQOLRQGNF-UHFFFAOYSA-N stemonine Chemical compound O1C2(C=C(C)C(=O)O2)C(CC)C(C2CC3)C1CCCN2C3C1CC(C)C(=O)O1 UINUUSQOLRQGNF-UHFFFAOYSA-N 0.000 claims description 9
- HTLBMAZNGBFLEY-UHFFFAOYSA-N stemonine-C17 Natural products O1C(=O)C(C)CC1C1N2CCCC3OC(=O)C(C)C3C2CC1 HTLBMAZNGBFLEY-UHFFFAOYSA-N 0.000 claims description 9
- 239000001845 taraxacum officinale leaf extract Substances 0.000 claims description 9
- ANZUDYZHSVGBRF-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol Chemical compound CCCCCCC(O)(CC)C(O)CO ANZUDYZHSVGBRF-UHFFFAOYSA-N 0.000 claims description 7
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 7
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 7
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims description 7
- 229960003237 betaine Drugs 0.000 claims description 7
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims description 7
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 7
- 229960000367 inositol Drugs 0.000 claims description 7
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 7
- UWJJYHHHVWZFEP-UHFFFAOYSA-N pentane-1,1-diol Chemical compound CCCCC(O)O UWJJYHHHVWZFEP-UHFFFAOYSA-N 0.000 claims description 4
- 235000005979 Citrus limon Nutrition 0.000 claims description 3
- 244000131522 Citrus pyriformis Species 0.000 claims description 3
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 3
- 230000003255 anti-acne Effects 0.000 claims description 3
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 3
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 17
- 230000002421 anti-septic effect Effects 0.000 abstract description 4
- 239000000047 product Substances 0.000 description 65
- 210000003491 skin Anatomy 0.000 description 27
- 230000002829 reductive effect Effects 0.000 description 18
- 230000000052 comparative effect Effects 0.000 description 15
- 230000000844 anti-bacterial effect Effects 0.000 description 11
- 238000003760 magnetic stirring Methods 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 9
- 235000011187 glycerol Nutrition 0.000 description 8
- 230000028327 secretion Effects 0.000 description 7
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 5
- 241001671204 Stemona Species 0.000 description 5
- 230000002159 abnormal effect Effects 0.000 description 5
- 241000186427 Cutibacterium acnes Species 0.000 description 4
- 201000004624 Dermatitis Diseases 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 239000004519 grease Substances 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 229940055019 propionibacterium acne Drugs 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 210000001732 sebaceous gland Anatomy 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical group OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 3
- 206010040880 Skin irritation Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 238000005536 corrosion prevention Methods 0.000 description 3
- 238000011056 performance test Methods 0.000 description 3
- 239000012466 permeate Substances 0.000 description 3
- 239000000419 plant extract Substances 0.000 description 3
- 231100000475 skin irritation Toxicity 0.000 description 3
- 230000036556 skin irritation Effects 0.000 description 3
- 229920000832 Cutin Polymers 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- 241000006808 Sessiliflorae Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000033115 angiogenesis Effects 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 210000000736 corneocyte Anatomy 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 239000009313 kushen Substances 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 238000005063 solubilization Methods 0.000 description 2
- 230000007928 solubilization Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 241000205585 Aquilegia canadensis Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 235000001553 Betula platyphylla Nutrition 0.000 description 1
- 241001313086 Betula platyphylla Species 0.000 description 1
- 235000009024 Ceanothus sanguineus Nutrition 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 102000012422 Collagen Type I Human genes 0.000 description 1
- 108010022452 Collagen Type I Proteins 0.000 description 1
- 102000001187 Collagen Type III Human genes 0.000 description 1
- 108010069502 Collagen Type III Proteins 0.000 description 1
- 240000004784 Cymbopogon citratus Species 0.000 description 1
- 235000017897 Cymbopogon citratus Nutrition 0.000 description 1
- 241000208680 Hamamelis mollis Species 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 208000001126 Keratosis Diseases 0.000 description 1
- 240000003553 Leptospermum scoparium Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 description 1
- 108010016113 Matrix Metalloproteinase 1 Proteins 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 102000005353 Tissue Inhibitor of Metalloproteinase-1 Human genes 0.000 description 1
- 108010031374 Tissue Inhibitor of Metalloproteinase-1 Proteins 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 206010046865 Vaccinia virus infection Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000000922 anti-bactericidal effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 229940059958 centella asiatica extract Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000004939 coking Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000004660 morphological change Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 208000007089 vaccinia Diseases 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940118846 witch hazel Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/738—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/49—Solubiliser, Solubilising system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/524—Preservatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
Description
原料 | 实施例1 | 实施例2 | 实施例3 | 实施例4 | 实施例5 |
水 | 94.34 | 83.2 | 70.2 | 81.1 | 77.9 |
增稠剂 | 0.1 | 0.5 | 1 | 0.5 | 0.5 |
香菇菌丝体提取物 | 2 | 3 | 10 | 5 | 8 |
天然植物促渗剂 | 0.2 | 0.5 | 1 | 0.6 | 0.8 |
苦参百部素 | 2 | 8 | 10 | 8 | 8 |
防腐剂 | 0.3 | 0.5 | 0.8 | 0.5 | 0.5 |
保湿剂 | 0.5 | 1.5 | 2 | 1.5 | 1.5 |
苦橙叶精油 | 0.02 | 0.6 | 1 | 0.6 | 0.6 |
月桂精油 | 0.02 | 0.6 | 1 | 0.6 | 0.6 |
柠檬香茅精油 | 0.02 | 0.6 | 1 | 0.6 | 0.6 |
增溶剂 | 0.5 | 1 | 2 | 1 | 1 |
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111343645.1A CN114053175B (zh) | 2021-11-13 | 2021-11-13 | 一种祛痘产品及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111343645.1A CN114053175B (zh) | 2021-11-13 | 2021-11-13 | 一种祛痘产品及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114053175A CN114053175A (zh) | 2022-02-18 |
CN114053175B true CN114053175B (zh) | 2023-06-06 |
Family
ID=80272335
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111343645.1A Active CN114053175B (zh) | 2021-11-13 | 2021-11-13 | 一种祛痘产品及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114053175B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115813822A (zh) * | 2022-12-16 | 2023-03-21 | 厦门海尼生物科技有限公司 | 一种高效祛痘组合物及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003048821A (ja) * | 2001-08-03 | 2003-02-21 | Hitoshi Nagaoka | 皮膚美白作用剤 |
CN104905996A (zh) * | 2014-03-10 | 2015-09-16 | 玫琳凯有限公司 | 皮肤美白组合物 |
CN106110327A (zh) * | 2016-08-03 | 2016-11-16 | 浙江添月生物科技有限公司 | 祛痘霜 |
CN112870123A (zh) * | 2021-01-29 | 2021-06-01 | 科丝美诗(中国)化妆品有限公司 | 一种保湿修护乳霜及其制备方法和应用 |
-
2021
- 2021-11-13 CN CN202111343645.1A patent/CN114053175B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003048821A (ja) * | 2001-08-03 | 2003-02-21 | Hitoshi Nagaoka | 皮膚美白作用剤 |
CN104905996A (zh) * | 2014-03-10 | 2015-09-16 | 玫琳凯有限公司 | 皮肤美白组合物 |
CN106110327A (zh) * | 2016-08-03 | 2016-11-16 | 浙江添月生物科技有限公司 | 祛痘霜 |
CN112870123A (zh) * | 2021-01-29 | 2021-06-01 | 科丝美诗(中国)化妆品有限公司 | 一种保湿修护乳霜及其制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
CN114053175A (zh) | 2022-02-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101064904B1 (ko) | 천연 추출물을 포함하는 여드름 개선용 화장료 조성물 | |
CN101732205A (zh) | 舒缓过敏皮肤、抗炎、抗刺激的护肤品组合物、制剂及其制备方法 | |
CN110731974B (zh) | 具有增强的抗炎功效的皮肤外用组合物 | |
CN103976914B (zh) | 一种三角风提取液及其制备方法和应用 | |
CN113693979B (zh) | 一种控油祛痘组合物及其应用 | |
CN110721117A (zh) | 一种美容护肤化妆品冻干粉制剂及其在溶液剂上的应用 | |
KR20190042883A (ko) | 반려동물 피모 관리용 조성물 | |
CN114053175B (zh) | 一种祛痘产品及其制备方法 | |
CN113893209B (zh) | 一种祛痘修护功能组合物、其在化妆品中的应用和凝胶及制备方法 | |
CN108261361A (zh) | 一种含有细胞生长因子的祛痘修复膏及其制备方法 | |
CN115317417A (zh) | 一种含愈创木提取物的修护痘敏肌的组合物及其护肤品 | |
CN108542805B (zh) | 祛痘复方精油制剂及其制备方法和应用 | |
CN105434195A (zh) | 一种具有祛痘且抑制痘痕生成功能的组合物及其应用 | |
KR101274811B1 (ko) | 소엽추출물 및/또는 해금사추출물을 함유하는 여드름 예방및 치료용 조성물 | |
WO2007000651A1 (en) | Pharmaceutical and cosmetic compositions containing colostrum, tocopherols, zinc oxide and hyaluronic acid | |
CN113133967A (zh) | 一种牡丹精华液润肤面乳及其制备方法 | |
CN111514161B (zh) | 一种抗口腔溃疡制剂及其应用 | |
CN115414308B (zh) | 一种祛痘组合物及制备方法和应用 | |
CN111821230A (zh) | 一种防敏修复的化妆品组合物及其应用 | |
CN110613671A (zh) | 一种铁皮石斛精华乳及其制备方法 | |
CN115813841A (zh) | 去屑止痒组合物及制备方法、应用,洗发水及制备方法 | |
CN107028830B (zh) | 一种防止疤痕增生的药品及其制备工艺 | |
CN113304091B (zh) | 一种具有祛痘功效的美白保湿面膜及其制备方法 | |
CN114306106B (zh) | 皮肤用组合物及其用途 | |
CN114848721A (zh) | 一种含植物提取物的祛痘组合物及其制备应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240228 Address after: Room 404-4, No. 1134 Jimei North Avenue, Software Park Phase III, Xiamen Torch High tech Zone, Xiamen, Fujian Province, 361000 Patentee after: Xiamen Haini Xinchuang Biotechnology Co.,Ltd. Country or region after: China Address before: Building 102 # 7, No. 320 Tongji South Road, Jimei District, Xiamen City, Fujian Province, 361000 Patentee before: XIAMEN HAINI BIO-TECH Co.,Ltd. Country or region before: China |